AcruxASX:ACR -7.14% Operating Margin % is -74.20% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 945 Biotechnology companies, Acrux ranks worse than 57.67% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Acrux's Operating Income for the
six
months ended in Dec. 2025 was A$-1.29 Mil. Acrux's Revenue for the
six
months ended in Dec. 2025 was A$1.74 Mil. Therefore, Acrux's Operating Margin % for the quarter that ended in Dec. 2025 was -74.20%.
Good Sign:
Acrux Ltd operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Acrux's Operating Margin % or its related term are showing as below:
ASX:ACR'
s Operating Margin % Range Over the Past 10 Years
Min: -2058.64 Med: -581.31 Max: 68.92
Current: -181.17
ASX:ACR's Operating Margin % is ranked worse than 57.67% of 945
companies
in the Biotechnology industry
Industry Median: -86.89
vs ASX:ACR: -181.17
Acrux's 5-Year Average Operating Margin % Growth Rate was 25.00% per year.
Acrux's Operating Income for the
six
months ended in Dec. 2025 was A$-1.29 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was A$-5.09 Mil.
Warning Sign:
Acrux Ltd has never been profitable in the past 3 years. It lost money every year.
Acrux (ASX:ACR) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Acrux Operating Margin % Related Terms
Acrux Operating Margin % Historical Data
* Premium members only.
The historical data trend for Acrux's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ACR vs VRTX, REGN, ALNY: Operating Margin % Comparison
For the Biotechnology subindustry, Acrux's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acrux Operating Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Acrux's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Acrux's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Acrux's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acrux (ASX:ACR) has a Operating Margin % of -74.20% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Acrux and its competitors. According to the industry distribution chart, Acrux ranks #545 out of 945 companies in the Biotechnology industry, placing it in the top 57.7%.
Is Acrux's Operating Margin % too high?
Acrux's current Operating Margin % is -74.20%. Based on the distribution chart, Acrux ranks #545 out of 945 companies in the Biotechnology industry, which is below the industry midpoint.
How does Acrux's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Acrux ranks #545 out of 945 companies for Operating Margin %. This places Acrux in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Acrux and its competitors. Acrux's current Operating Margin % is -74.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acrux stock overvalued right now?
Based on GuruFocus' analysis, Acrux (ASX:ACR) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.03, compared to a current price of A$0.01 — trading 56.7% below its estimated fair value. The current Operating Margin % is -74.20%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Acrux (ASX:ACR), the current Operating Margin % is -74.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Acrux Ltd is a dynamic Australian drug delivery specialist with expertise in developing and commercialising patient-preferred healthcare products for world-wide markets. Its talent creates value through the development and commercialisation of healthcare products using owned or acquired technologies. The group's products are patient preferred, protected by patent or other means, and use creative drug delivery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ACR has been successfully added to your 